Early Cancer Detection in the Workplace: Why SMEs Can't Afford to Wait
You've heard it before, but the numbers still shock: when cancer is caught early, survival rates jump from 26% to 91%. That's not just another health statistic. That's the difference between going home to your family and not. For small and medium-sized enterprises (SMEs), early cancer detection through workplace screening isn't just a health initiative; it's a business imperative that saves lives and money.1
Here's the hard truth: cancer is the number one healthcare cost driver for employers today.2 It accounts for 16% of employer healthcare spending and is growing at 9% annually, nearly double the general healthcare inflation rate.3 By 2025, cancer costs are projected to consume 20-25% of high-cost claims.4 For SMEs operating on tight margins, this isn't sustainable. One employee's cancer diagnosis can trigger an 11% premium increase across your entire workforce.5 But there's a pathway forward: workplace cancer screening catches disease early when treatment costs 2-4 times less and survival odds are dramatically higher.6
The challenge is that 85% of cancer workers are employed by companies with fewer than 500 employees.7 SMEs carry the burden but lack the resources to manage it. Yet the research is clear: SMEs can implement effective cancer screening programmes without breaking their budgets. For every pound spent on wellness programmes, employers save £2-3 in healthcare costs alone.8 Add in productivity gains and reduced absenteeism, and the return on investment becomes impossible to ignore.
This article explains why early cancer detection matters for your business and your employees, reveals the financial case that justifies investment, and shows you exactly how SMEs can implement practical screening strategies right now.
Why Early Detection Changes Everything: The Survival Advantage
The gap between catching cancer early and late is staggering. A woman diagnosed with early-stage breast cancer has a 99% chance of surviving five years. The same woman diagnosed with advanced cancer has only a 31% chance.9 That 68-percentage-point difference represents the most powerful intervention available in modern medicine.
This pattern holds across all major cancer types. Colorectal cancer caught early: 91% five-year survival. Caught late: 13%.10 Cervical cancer caught early: 92% survival. Caught late: 20%.11 Lung cancer detected through screening: 87% five-year survival. Diagnosed through symptoms: 39%.12 When you look across all cancers combined, early-stage disease averages 91% five-year survival, whilst late-stage averages only 26%; roughly four times better odds.13
But the survival benefit is only part of the story. Early detection transforms the patient experience itself.
When cancer is caught early, doctors often can treat it with surgery alone. A woman with early-stage breast cancer might need a lumpectomy and several weeks of radiation. Finished. Life returns to normal within months. Late-stage cancer requires months of chemotherapy, with severe side effects: hair loss, nausea, organ damage, and hospitalisation. The treatment itself becomes a second illness.
Beyond treatment intensity, early detection means more treatment choices. Early cancer may be curable with minimal intervention. Late cancer limits options to aggressive chemotherapy, radiation, or palliative (comfort) care. For the patient, this means the difference between a treatment plan that allows them to work, spend time with family, and maintain dignity, versus a treatment plan that consumes their life.
Figure 1: Five-year survival rates for early-stage versus late-stage cancers across major cancer types. Early detection increases survival odds by 48-78 percentage points, representing the most powerful intervention available to prevent cancer mortality.1
For employers, the differences are equally striking. An employee with early-stage cancer might take six weeks off for surgery and recovery. With chemotherapy, the same employee takes six months off each year.14 Early detection means shorter absence, faster return to productivity, and preserved institutional knowledge.
The Financial Case: Why SMEs Must Act Now
Here's what's happening to your healthcare costs: cancer spending is accelerating. Nationally, employers face $200 billion in annual cancer costs, projected to reach $222-240 billion by 2025-2030.15 For individual companies, cancer represents at least 15-16% of total health spending and is climbing to 25% for high-cost claims.16 Without intervention, this becomes unaffordable.
The mathematics are brutal. A single cancer case costs an employer approximately $43,516 in year one, with ongoing treatment costs of roughly $10,000 per month.17 Newer cancer drugs run $20,000-$40,000 per month, some reaching $1 million-plus for gene or cell therapies.18 That single diagnosis can devastate an SME's insurance costs, trigger premium increases for all employees, and deplete the company's financial reserves.
Beyond direct treatment costs, employers face productivity losses. An employee undergoing cancer treatment misses an average of 22 additional workdays per year.19 Presenteeism (working whilst ill or in pain) costs as much as absenteeism or more; workers with cancer show 25-30% reduced productivity even when present.20 For employees with breast cancer specifically, the average is six months absent per year.21 For a small company with 20 employees, this equals one full-time employee being absent all year.
Here's the counterargument that changes the equation: early detection cuts treatment costs by 50-75%.22 When cancer is caught at stage 1, treatment might cost $20,000-$40,000. Caught at stage 4, the same cancer costs $75,000-$100,000 plus.23 That $40,000-$60,000 difference per employee is the opportunity cost of not screening.
Now consider workplace health programmes broadly. Research shows that for every pound invested in wellness programmes, employers save £2-£3.27 in reduced healthcare costs alone.24 Add in absenteeism reduction (25-30% fewer sick days) and productivity gains (up to 20% higher output), and the total return reaches £6 for every £1 spent.25 This is not speculation; this is documented across 95% of companies measuring wellness programme ROI.26
The most telling statistic: one real workplace cancer screening programme detected early breast cancer in 12 employees. Based on the cost differential between early and late treatment, that programme returned 16 times its original investment.27
Figure 2: Return on investment showing the financial multiplier effect of wellness programmes. Every pound spent generates returns of £2-6 in reduced healthcare costs, lower absenteeism, and improved productivity.2
For SMEs specifically, the business case is even more compelling because they lack the negotiating power of large employers. Whilst large companies with 5,000-plus employees can implement centres of excellence, negotiate bundled pricing, and absorb cost shocks through risk pooling, SMEs cannot. A single cancer diagnosis can trigger a company-wide premium increase. This makes prevention and early detection not a nice-to-have; it's essential.
The Survival Gap: Who's Being Missed
Despite the clear benefits, screening participation remains suboptimal. Current rates show: 80% of women over 50 get mammograms, but only 62% of women aged 40-49.28 For colorectal cancer screening, participation stands at just 57% of eligible adults (significantly below the 80% target).29 Cervical cancer screening is higher at 84%, but even this leaves gaps.30 These participation gaps represent tens of thousands of preventable diagnoses and deaths annually.
The barriers are real. Working people struggle to prioritise medical appointments amid professional demands. Screening involves time away from work, navigation of healthcare systems, and emotional barriers around procedures that feel invasive or embarrassing. For uninsured or underinsured employees, the cost becomes prohibitive. For rural or dispersed workforces, geography creates access barriers.
But here's what research reveals: when you remove barriers, participation jumps dramatically. One workplace intervention targeting Latino workers increased colorectal cancer screening participation from 14% to 57% (a four-fold improvement) simply through education and navigation support.31 A breast cancer awareness programme increased screening rates by 7.2% just through providing information and resources.32 When employers offer paid time off for screening, participation increases significantly.33 When screening is free or subsidised through partnerships, cost barriers disappear.
This means the participation gap isn't a reflection of employee disinterest. It's a reflection of unmet needs. Employees will participate when you remove barriers.
Workplace Screening Works: Evidence from Real Programmes
The evidence that workplace cancer screening interventions are effective is strong. A systematic review of 22 workplace cancer screening interventions found that 18 (82%) showed positive outcomes for increasing screening participation.34 More importantly, some programmes achieved large improvements: 30-plus percentage point increases in screening rates.35
Consider specific examples:
Breast cancer screening: Workplace education programmes increased mammography rates by 4.7-7.2% in participating employees.36 This may sound modest until you realise it means dozens more women per company getting screened early.
Colorectal cancer screening: This area showed the largest opportunity and the biggest returns. One workplace intervention using community health workers increased screening from 13.8% to 56.9% (a more than four-fold jump).37 The reason: community health workers addressed fear and embarrassment through peer messaging, provided specific information about screening locations and what to expect, and offered navigation support to help schedule appointments.
Cervical cancer screening: Educational workplace programmes increased Pap test rates by 1.9-4.7%.38 Whilst baseline rates are already high at 84%, any improvement means women are prevented from developing cervical cancer.
Multi-cancer approach: One workplace programme using community health workers reached 77% of eligible women with cancer education and arranged screening for 25% of those reached.39
The consistency across all these programmes reveals an important insight: workplace cancer screening interventions work because they address the barriers people actually face. They don't require expensive on-site screening facilities. Most successful programmes use the "awareness and referral" model: educate employees about screening importance and specific locations, provide information about what to expect, remove time barriers through paid time off, and offer navigation support.
Figure 3: Current screening participation rates compared to national targets, showing opportunity for workplace interventions to close gaps. Colorectal cancer screening (57%) and breast cancer screening in younger women (62%) present the greatest opportunities for improvement.3
The Occupational Angle: High-Risk Workers Need Special Attention
For certain industries, workplace cancer screening isn't just recommended; it's critical. Between 2-8% of all cancers worldwide are caused by workplace exposures to carcinogens, and in developed countries like the UK, the figure reaches 3.5-5%.40 Globally, approximately 666,000 fatal work-related cancers occur annually.41
Construction workers face 57% higher lung cancer mortality compared to the general population, primarily from asbestos, silica dust, and diesel exhaust exposure.42 Firefighters experience 9% higher cancer incidence and 14% greater cancer mortality.43 Pilots face a six times higher melanoma risk from occupational exposures.44 Iron and steel workers show 500% higher lung cancer incidence than the general population.45
For SMEs employing workers in these high-risk occupations, targeted screening becomes a legal and moral obligation. The UK's Health and Safety at Work Act 1974 and the Management of Health and Safety at Work Regulations 1999 establish employer duties to protect workers and conduct health surveillance where hazardous exposures exist.46 In the US, OSHA requires health monitoring for workers exposed to occupational carcinogens.
Moreover, it's smart business. Workers diagnosed early with occupational cancer have dramatically better outcomes. A roofer diagnosed with early-stage lung cancer has vastly better treatment options and prognosis than one diagnosed at stage 4 after years of exposure. For construction companies, manufacturing firms, mining operations, and other high-risk employers, workplace screening for occupational cancers becomes a core responsibility.
Affordable Screening Strategies SMEs Can Implement Now
The most common objection SMEs raise to workplace screening is cost. And it's understandable: 52% of SMEs cite cost as a barrier to health and wellbeing support, and 49% cite lack of time and resources.47 Yet research shows these barriers are largely psychological, not actual. Basic cancer screening awareness programmes cost £0-£300 per year. Even comprehensive programmes cost £300-£500 annually. Given the £2-6 return per pound spent, the maths are compelling.
Here's what SMEs can actually implement:
Starting Point One: Tobacco Control (Easiest, Highest Impact)
Smoking is the single most preventable cause of cancer. Tobacco cessation prevents lung, throat, bladder, mouth, and pancreatic cancers. The cost to implement: less than £0.40 per employee per month through free state quit-lines and counselling support.48
Most SMEs already have smoke-free policies. The missing piece is cessation support. Pair your smoke-free policy with free access to the national smoking helpline (0300 123 1044 in England; equivalent numbers in Scotland, Wales, Northern Ireland) and free cessation medications through NHS services. The programme costs virtually nothing, yet directly prevents cancer.
Starting Point Two: Awareness Education (Low Cost, Proven Effective)
Select one cancer type: breast, cervical, or colorectal. Launch education during that cancer's awareness month. October for breast cancer, January for cervical cancer, and March for colorectal cancer.
Partner with your local health department, hospital system, or American Cancer Society equivalent. They provide:
- Free educational materials
- Free speaker programmes
- Information about local screening locations
- Screening guidelines and fact sheets
Your role: distribute materials, send emails, post posters, and perhaps host a speaker event. Cost: £0-£250. Time commitment: 4-6 weeks of coordination by one person.
The materials should answer the questions employees actually have: What age should I start screening? What does the screening involve? Where can I get screened near my workplace? Does my insurance cover it? What's the cost if uninsured? Make it simple, non-scary, and actionable.
Starting Point Three: Paid Time Off for Screening (Zero Cost, High Impact)
Update your employee handbook with a simple statement: "Employees may take paid time off for cancer screening appointments." This removes the biggest barrier to participation: time. Employees don't have to choose between their job and their health.
Provide a one-page guide: "Cancer Screening in [Your City]" listing specific breast cancer, cervical cancer, and colorectal cancer screening locations, phone numbers, and whether insurance or sliding-scale fees apply.
Cost: £0. Time: 2 hours to write the policy and create the guide. Impact: significant participation increase, especially for employees who want to get screened but can't justify unpaid time off.
Starting Point Four: Mobile Screening Events (Moderate Cost, High Impact)
Contact your local health department, Federally Qualified Health Center (FQHC), or primary care network. Many offer mobile health clinics that come to you. A mobile mammography van, colorectal screening clinic, or cervical cancer screening can be arranged for 1-2 days on your premises.
Cost: typically £40-£100 per screening when you pool with 2-3 other SMEs. A company with 30 employees participating would cost roughly £1,200-£3,000 for an all-day screening event covering multiple cancer types. Split among 3 companies, that's £400-£1,000 per company (a one-time cost that screens 90 employees and likely detects early cancers that would have cost £20,000-£40,000 to treat late).
The logistics: your role is providing parking space, communicating dates to employees, and collecting sign-ups. The health partner brings the clinic, nurses, and equipment.
Starting Point Five: Health Savings Account (HSA) and Insurance Coverage Optimisation
Verify that your health insurance plan covers recommended cancer screenings at no or low cost. Under the Affordable Care Act (US) and NHS guidance (UK), cancer screenings rated "A" or "B" by preventive services task forces are covered without cost-sharing.49 Ensure your plan documentation makes this clear to employees.
For uninsured employees, connect them with free screening programmes: the National Breast and Cervical Cancer Early Detection Program (US) provides free breast and cervical cancer screening for uninsured women. Many states offer free colorectal cancer screening through CDC programmes. Community health centres offer sliding-scale fees based on income.
Cost: £0. Impact: eliminates financial barriers for your workforce.
Removing the Real Barriers: What Employees Actually Need
Beyond programme design, success requires understanding and removing the barriers employees face.
The time barrier: Employees believe screening requires hours away from work. Reality: most screening takes 30 minutes to 1 hour. But they still need time off, travel time, and appointment scheduling time. Solution: paid time off explicitly for screening, plus information that screening doesn't take the whole day. A 30-minute mammogram plus 30 minutes travel is a 1-hour commitment, not a full afternoon.
The fear barrier: Many employees avoid screening because they fear a cancer diagnosis. The psychology is understandable but counterproductive: "If I don't get tested, I won't have cancer." Solution: reframe messaging around hope and early detection. "Screening catches cancer when it's most treatable" and "99% of early-stage breast cancers are five-year survivors" shift fear to empowerment. Share peer stories; for example: "Sarah got her colonoscopy, felt fine, and went back to work the same day."
The embarrassment barrier: Cervical and colorectal screenings involve intimate procedures. Employees fear judgment and privacy breaches. Solution: assure strict confidentiality ("Company will never know if you screen or what results are"), use peer messaging ("Women do this every day; doctors have seen everything"), and describe the procedure simply ("30-minute procedure, you're asleep, wake up when done").
The location barrier: Employees don't know where to get screened. "Get cancer screening" is too vague. Solution: provide specific locations with addresses and phone numbers. Create a simple guide: "For breast cancer screening, call [clinic name] at [number]" or "Visit [website] for locations near your home."
The cost barrier: Uninsured or underinsured employees can't afford screening. Solution: verify insurance coverage, offer to cover copays for insured employees, and connect uninsured employees to free programmes.
The dispersed workforce barrier: Field workers, remote employees, and those with irregular schedules can't attend an office-based programme. Solution: offer flexible screening options: mobile clinics at multiple sites, extended hours (evenings/weekends), partnerships with multiple clinics so employees can choose the most convenient location, and digital reminders via email or text.
When you systematically address these barriers, participation jumps. The colorectal cancer programme that increased screening from 14% to 57% didn't require expensive facilities; it used community health workers who addressed barriers directly.
Figure 4: Breakdown of return on investment showing how wellness programmes generate returns through multiple pathways: direct healthcare cost reductions (£3.27 per pound spent), absenteeism reduction (£2.73 per pound), and productivity improvements.4
The Implementation Reality: Practical Steps for SMEs
Getting started doesn't require elaborate planning. Research on successful SME workplace health programmes identifies a realistic implementation pathway:
Weeks 1-3: Assessment and planning
Calculate your baseline. If you offer health insurance, estimate what percentage goes to cancer (typically 16%). This becomes your business case. Meet with leadership, explain the £2-6 return on investment, and get approval for a small pilot programme. Designate one person (even part-time, 2-4 hours per week) as the wellness coordinator. This single decision increases programme success by 10-fold.50
Weeks 4-5: Build partnerships
Call your local health department, county health authority, hospital system, or primary care network. Say: "We want to help our employees with cancer screening and prevention. What resources or programmes can we partner on?"
Most health departments have free materials, speaker programmes, and screening partnerships. The American Cancer Society (cancer.org) provides free workplace toolkits. Susan G. Komen offers breast cancer resources. These aren't offered because they're easy; they're offered because health agencies want to reach working populations.
Month 2: Launch
Choose your starting strategy: tobacco control, awareness education, paid time off policy, or mobile screening. Start with the easiest option that fits your workforce. If you have smokers, start with tobacco control. If your workforce skews female over 50, start with breast cancer awareness. If your workers are aged 45-75, start with colorectal cancer education.
Communication is everything. Send an email from leadership: "We care about your health. Starting this month, we're offering [programme type]. Here's why it matters, how to participate, and what to expect."
Months 3-6: Measure and communicate
Track participation: how many employees attended the education session, took the informational materials, and scheduled screening appointments? Track any health plan data on screening rates before and after. Calculate cost: if the programme costs £300 and results in one early cancer detection saving £40,000 in treatment, your return on investment is 133:1.
Share results with employees: "Twelve of you participated in our breast cancer screening programme. Two of you found early-stage cancer. Early detection changes everything." This social proof motivates others to participate next year.
Year 2: Expand
Based on year 1 results, add a second cancer type, expand to occupational health screening if you have high-risk workers, or deepen your tobacco cessation support. Build on what worked.
Real-World Success: What Working Programmes Look Like
The most instructive case study comes from a workplace cancer screening programme that detected early breast cancer in 12 employees. These 12 women, if they had not been screened, likely would have presented with symptoms later, increasing treatment costs by £40,000-£60,000 per person. That's £480,000-£720,000 in treatment costs prevented. If the programme costs £30,000-£50,000, the return is 10-20 times the investment.51
More broadly, research on workplace interventions shows consistent patterns:
A "Woman to Woman" study partnering with employers to promote breast and cervical cancer screening found that workplace education increased recent mammograms by 7.2%, clinical breast exams by 5.8%, and Pap tests by 4.7%.52 This was simple education: no on-site screening, no screening facilities, just information and communication.
Another programme targeting Latino workers combined education with navigation support (helping schedule appointments and removing barriers). Colorectal cancer screening knowledge increased from 50% to 81%. Actual screening participation jumped from 14% to 57%.53 The difference? Peer educators and personal navigation made screening accessible.
Community health worker models consistently outperform distant, professional-only approaches. When someone like the employee (speaking their language, looking like them, sharing their community context) provides information and support, participation increases dramatically. This is not expensive. Community health workers can be trained employees or trusted local partners.
Occupational Health and Prevention: Prevention Beyond Screening
For some occupational groups, prevention becomes equally important to screening. Construction workers with asbestos exposure, miners with silica dust exposure, and agricultural workers with pesticide exposure benefit from both early detection through screening and exposure reduction through prevention.
The workplace regulations framework in the UK (COSHH, Health and Safety at Work Act) and in the US (OSHA) establishes that employers must control hazardous exposures "as low as is reasonably practicable".54 This includes engineering controls (ventilation, enclosure), substitution of less hazardous alternatives, and personal protective equipment. For SMEs in these industries, compliance with exposure limits is both a legal requirement and a cancer prevention strategy.
Beyond regulatory compliance, SMEs should recognise that occupational cancer prevention creates a competitive advantage. Employers who prioritise occupational health attract better workers, retain staff longer, and avoid the reputational damage of workplace-related cancer diagnoses. In tight labour markets, this matters.
For construction companies, manufacturing, mining, and agricultural businesses, implementing occupational health screening and exposure control isn't an add-on; it's foundational to responsible business.
The Sustainability Question: Making Programmes Last
One barrier to workplace health programmes is sustainability. Many SMEs launch a programme, see initial enthusiasm, and then it fades when the coordinator gets busy or the initial funding runs out. Research identifies key factors for sustaining programmes:
1. Embed it in policy, not just programming. A paid time off policy for screening is permanent. A one-time awareness campaign is temporary. Sustainability requires structural changes: policies, budgets, and roles (not just one-off initiatives).
2. Designate clear responsibility. When no one owns the programme, it dies. A designated wellness coordinator (even part-time) ensures continuity. Importantly, this person shouldn't burn out; they need support, clear expectations (2-4 hours per week), and access to partner resources so they're not creating content from scratch.
3. Build partnerships that sustain you. Government health departments, non-profit organisations, and primary care networks have ongoing programmes. When you partner with them rather than building everything yourself, you tap into their sustainable infrastructure. They have budgets, staff, and materials. You provide the connection to your employees.
4. Measure and communicate. Programmes that show results get sustained. If leadership sees data showing that your programme increased screening by 10% and likely detected cancer early, they'll fund it next year. If there's no data, it seems like overhead.
5. Make it normal, not special. Smoking cessation support should be a standing employee benefit, like health insurance. Cancer screening information should be in onboarding. Annual health awareness campaigns should be scheduled. When these become part of the organisation's rhythm, they sustain themselves.
Looking Forward: Emerging Technologies and Future-Ready Programmes
Cancer screening is evolving rapidly. Blood tests that detect multiple cancers from a single draw are moving through clinical trials and receiving regulatory approval. The Shield blood test received FDA approval in July 2024 for colorectal cancer detection.55 Research shows pancreatic cancer can be detected with over 90% accuracy using a four-marker blood test.56 HPV-related head and neck cancers can be detected years before symptoms appear with 99% sensitivity using DNA detection methods.57
These emerging tests won't immediately replace traditional screening (they're still being validated), but they represent the future. SMEs should monitor these developments. Within 5 years, a simple annual blood test might screen for 50-plus cancer types simultaneously. This would transform workplace screening feasibility.
In the near term, SMEs should focus on current evidence-based screening: mammography, colonoscopy, HPV testing for cervical cancer, and low-dose computed tomography for high-risk smokers. But thinking long-term, workplace screening programmes built now position companies to evolve as technology improves.
The Conversation SME Leaders Should Have Today
If you lead an SME, the question isn't whether to invest in workplace cancer screening. The question is which strategy to start with and how quickly.
The data is unambiguous:
- Early cancer detection saves lives (91% vs. 26% survival)
- Workplace screening interventions increase participation (4-56% improvements documented)
- Wellness programmes return £2-6 for every pound invested
- One-time cancer programmes save tens of thousands of pounds per early detection
- Implementation costs are manageable (£0-£500 for year one)
What SMEs lack isn't evidence or financial justification. They lack confidence that they can implement something effective despite limited resources. This article proves you can. You don't need an expensive wellness provider, an on-site health clinic, or a large dedicated staff. You need:
- Leadership commitment
- One designated coordinator (part-time is fine)
- Partnerships with your local health department and nonprofits
- Clear, simple messaging
- Systematic removal of participation barriers
Start today. Call your local health department and ask about cancer screening partnerships. Designate your wellness coordinator. Choose one cancer type for awareness month. You'll be amazed at how quickly the programme gains traction.
Your employees are getting cancer diagnoses every year. Some are caught early (99% survive). Some are caught late (31% survive). The difference isn't luck. The difference is whether screening happened. Your workplace screening programme directly determines whether your employees fall into the first group or the second.
That's not just health. That's business. That's human.
Further Reading
Workplace Cancer Screening and Prevention Implementation
- American Cancer Society - Workplace Resources and Toolkits
- CDC - Breast and Cervical Cancer Screening Success Stories and Workplace Policies
- Johns Hopkins HealthCare Solutions - How Employers Can Promote Cancer Screenings
- SME Workplace Cancer Screening: Practical Implementation Checklist
Early Cancer Detection and Survival Outcomes
- National Cancer Institute - Cancer Screening Overview
- American Cancer Society - Cancer Statistics and Survival Rates
- Harvard Health - How Well Do Colonoscopies Prevent Colorectal Cancer
- U.S. Preventive Services Task Force - Cancer Screening Recommendations
Financial Impact and ROI of Wellness Programmes
- Wellhub - Return on Investment for Corporate Wellness Programs
- Macorva - Evaluating ROI for Employee Wellness Programs: Updated Insights for 2025
- University of Michigan - Cancer Screenings Have Saved the U.S. at Least $6.5 Trillion
- Business Group on Health - Taking Action on Cancer: A Business Viewpoint
Occupational Cancer Risks and Prevention
- CDC NIOSH - Occupational Cancer Overview
- HSE - Cancer and Construction: Key Points
- Cancer Research UK - Cancer Risks in the Workplace
- Safety and Health at Work EU-OSHA - Work-Related Cancer
Barriers and Solutions for SME Implementation
- MDPI - Workplace Health and Wellbeing in Small and Medium Sized Enterprises
- Frontiers in Public Health - Barriers to Implementation of Workplace Health Interventions
- Health Promotion in Small Business: A Systematic Review
- CDC/NIOSH - Small Business Safety and Health
Regulatory Framework and Legal Requirements
- Health and Safety Executive - COSHH and Occupational Health Surveillance
- UK Government - Occupational Health Training for SMEs
- OSHA - Laws and Regulations for US Employers
- OSHA - Free Consultation Services for Small Businesses
Employee Resources and Support
- American Cancer Society - Support Programs and Services
- Susan G. Komen - Breast Cancer Resources
- National Breast and Cervical Cancer Early Detection Program - Free/Low-Cost Screening
- Smokefree.gov - Free Smoking Cessation Resources
References
- National Cancer Institute. Cancer Screening and Detection. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/types/breast/hp/breast-screening-pdq
- Business Group on Health. Employers Cite Cancer as Top Healthcare Cost Driver. [Internet]. [cited 2026 Apr 7]. Available from: https://www.businessgrouphealth.org/resources/pov-taking-action-on-cancer
- Cigna. 15 Stats Illustrating Cancer's Impact on People, Employers, and Health Care Costs. [Internet]. [cited 2026 Apr 7]. Available from: https://newsroom.cigna.com/15-stats-illustrating-cancers-impact-on-people-employers-and-health-care-costs
- Cigna. 15 Stats Illustrating Cancer's Impact on People, Employers, and Health Care Costs. [Internet]. [cited 2026 Apr 7]. Available from: https://newsroom.cigna.com/15-stats-illustrating-cancers-impact-on-people-employers-and-health-care-costs
- Peterson-KFF Health System Tracker. How Much and Why Premiums are Going Up for Small Businesses in 2026. [Internet]. [cited 2026 Apr 7]. Available from: https://www.healthsystemtracker.org
- National Cancer Institute. Economic Impact of Cancer Screening. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/about-cancer/screening
- Cigna. 15 Stats Illustrating Cancer's Impact on People, Employers, and Health Care Costs. [Internet]. [cited 2026 Apr 7]. Available from: https://newsroom.cigna.com/15-stats-illustrating-cancers-impact-on-people-employers-and-health-care-costs
- Wellhub. Return on Investment for Corporate Wellness Programs. [Internet]. [cited 2026 Apr 7]. Available from: https://wellhub.com/en-us/blog/press-releases/study-reveals-strong-return-on-investment-for-corporate-wellness-programs
- American Cancer Society. Breast Cancer Statistics and Survival Rates. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.org/cancer/types/breast/hp/breast-screening-pdq
- New England Journal of Medicine. Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. 2022;388(19):1769-1778.
- National Cancer Institute. Cervical Cancer Screening (PDQ). [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/types/cervical/hp/cervical-screening-pdq
- National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 2011;365(5):395-409.
- University of Michigan. Cancer Screenings Have Saved the U.S. at Least $6.5 Trillion. [Internet]. [cited 2026 Apr 7]. Available from: https://ihpi.umich.edu/news-events/news/cancer-screenings-have-saved-us-least-65-trillion-study-estimates
- CDC/MMWR. Medical Costs and Productivity Losses Associated with Cancer Survivors. Morbidity and Mortality Weekly Report. 2014;63(23).
- National Cancer Institute. The Economic Burden of Cancer in the United States. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/about-cancer/managing-care/track-care-costs
- Business Group on Health. Cancer as Percentage of Employer Healthcare Spend. [Internet]. [cited 2026 Apr 7]. Available from: https://www.businessgrouphealth.org
- National Cancer Institute. Cancer Care Costs by Stage. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/about-cancer/managing-care/track-care-costs
- Workplace Options. The True Cost of Cancer at Work: A Call for Greater Employer Support. [Internet]. [cited 2026 Apr 7]. Available from: https://www.workplaceoptions.com/blog/the-true-cost-of-cancer-at-work-a-call-for-greater-employer-support
- CDC/MMWR. Medical Costs and Productivity Losses Associated with Cancer Survivors. Morbidity and Mortality Weekly Report. 2014;63(23).
- National Cancer Institute. Cancer-Related Presenteeism in the Workplace. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov
- CDC/MMWR. Medical Costs and Productivity Losses Associated with Cancer Survivors. Morbidity and Mortality Weekly Report. 2014;63(23).
- Integrated Benefits Institute. Early Detection and Treatment Cost Reduction. [Internet]. [cited 2026 Apr 7]. Available from: https://news.ibiweb.org
- National Cancer Institute. Cancer Care Costs by Stage. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cancer.gov/about-cancer/managing-care/track-care-costs
- Harvard T.H. Chan School of Public Health. Wellness Program ROI Meta-Analysis. [Internet]. [cited 2026 Apr 7]. Available from: https://hsph.harvard.edu
- Wellhub. Return on Investment for Corporate Wellness Programs. [Internet]. [cited 2026 Apr 7]. Available from: https://wellhub.com/en-us/blog/press-releases/study-reveals-strong-return-on-investment-for-corporate-wellness-programs
- Macorva. Evaluating ROI for Employee Wellness Programs: Updated Insights for 2025. [Internet]. [cited 2026 Apr 7]. Available from: https://www.macorva.com/blog/evaluating-roi-for-employee-wellness-programs-updated-insights-for-2025
- Workplace Options. The True Cost of Cancer at Work: A Call for Greater Employer Support. [Internet]. [cited 2026 Apr 7]. Available from: https://www.workplaceoptions.com/blog/the-true-cost-of-cancer-at-work-a-call-for-greater-employer-support
- CDC. Use of Cancer Screening Tests, United States, 2023. Prev Chronic Dis. 2025;22:E6.
- CDC. Use of Cancer Screening Tests, United States, 2023. Prev Chronic Dis. 2025;22:E6.
- CDC. Use of Cancer Screening Tests, United States, 2023. Prev Chronic Dis. 2025;22:E6.
- PMC/NIH. A Workplace-Based Intervention to Improve Awareness, Knowledge, and Utilisation of Breast, Cervical, and Colorectal Cancer Screenings. PubMed. 2019.
- PMC/NIH. Promoting Breast and Cervical Cancer Screening at the Workplace: Results from the Woman to Woman Study. PubMed. 2007.
- Frontiers in Public Health. Barriers to Implementation of Workplace Health Interventions: An Economic Perspective. [Internet]. [cited 2026 Apr 7]. Available from: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1035064/full
- Frontiers in Oncology. Effectiveness of Workplace Cancer Screening Interventions: A Systematic Review. 2025. Available from: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1575820/full
- BMC Cancer. Effectiveness of Workplace Cancer Screening Interventions: A Systematic Review. 2024. Available from: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-024-12649-0
- PMC/NIH. Promoting Breast and Cervical Cancer Screening at the Workplace: Results from the Woman to Woman Study. PubMed. 2007.
- PMC/NIH. A Workplace-Based Intervention to Improve Awareness, Knowledge, and Utilisation of Breast, Cervical, and Colorectal Cancer Screenings. PubMed. 2019.
- PMC/NIH. Promoting Breast and Cervical Cancer Screening at the Workplace: Results from the Woman to Woman Study. PubMed. 2007.
- CDC. Community Health Worker Model Effectiveness. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cdc.gov/cancer/nbccedp
- CDC NIOSH. Occupational Cancer: Global and National Estimates. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cdc.gov/niosh/cancer/about/index.html
- International Labour Organization. Global Burden of Occupational Cancers. [Internet]. [cited 2026 Apr 7]. Available from: https://www.ilo.org
- HSE. Cancer and Construction: Key Points. [Internet]. [cited 2026 Apr 7]. Available from: https://www.hse.gov.uk/construction/healthrisks/cancer-and-construction/key-points.htm
- International Association of Fire Fighters. Cancer Risk in Firefighting. [Internet]. [cited 2026 Apr 7]. Available from: https://www.iaff.org
- Aviation Safety Network. Occupational Health Risks for Pilots. [Internet]. [cited 2026 Apr 7]. Available from: https://aviation-safety.net
- CDC NIOSH. Lung Cancer Risk in Iron and Steel Workers. [Internet]. [cited 2026 Apr 7]. Available from: https://www.cdc.gov/niosh/cancer/about/index.html
- Health and Safety Executive. Management of Health and Safety at Work Regulations 1999. [Internet]. [cited 2026 Apr 7]. Available from: https://www.hse.gov.uk
- MDPI. Workplace Health and Wellbeing in Small and Medium Sized Enterprises: A Mixed Methods Evaluation. 2024;22(1):90.
- Integrated Benefits Institute. Cost-Effectiveness of Smoking Cessation Programs. [Internet]. [cited 2026 Apr 7]. Available from: https://news.ibiweb.org
- Affordable Care Act. Preventive Services Without Cost-Sharing. [Internet]. [cited 2026 Apr 7]. Available from: https://www.healthcare.gov
- MDPI. Workplace Health and Wellbeing in Small and Medium Sized Enterprises: A Mixed Methods Evaluation. 2024;22(1):90.
- Workplace Options. The True Cost of Cancer at Work: A Call for Greater Employer Support. [Internet]. [cited 2026 Apr 7]. Available from: https://www.workplaceoptions.com/blog/the-true-cost-of-cancer-at-work-a-call-for-greater-employer-support
- PMC/NIH. Promoting Breast and Cervical Cancer Screening at the Workplace: Results from the Woman to Woman Study. PubMed. 2007.
- PMC/NIH. A Workplace-Based Intervention to Improve Awareness, Knowledge, and Utilisation of Breast, Cervical, and Colorectal Cancer Screenings. PubMed. 2019.
- Health and Safety Executive. COSHH Essentials: Workplace Exposure Limits. [Internet]. [cited 2026 Apr 7]. Available from: https://www.hse.gov.uk/coshh/basics/exposurelimits.htm
- FDA. Shield Blood Test for Colorectal Cancer Approved. [Internet]. July 2024. Available from: https://www.fda.gov
- ScienceDaily. New Blood Test Detects Pancreatic Cancer with Over 90% Accuracy. [Internet]. March 2026. Available from: https://www.sciencedaily.com/releases/2026/03/260323005540.htm
- ScienceDaily. HPV Blood Test Achieves 99% Sensitivity in Detecting Head and Neck Cancers. [Internet]. February 2026. Available from: https://www.sciencedaily.com/releases/2026/02/260216044002.htm

